Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1NET 1Head & Neck 1Gastrointestinal 1Endocrine 1Classical hematology 1

Conditions

Stomach Neoplasms 1Neuroendocrine Tumors 1Anemia, Iron-Deficiency 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 324Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Betaine × Gastrointestinal × Clear all
NCT06881511 2025-03-30

Exploratory Study on the Efficacy of Betaine Hydrochloride in Treating Autoimmune Gastritis

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Recruiting
100 enrolled
Classical hematologyEndocrineGastrointestinalNET

Stomach Neoplasms, Neuroendocrine Tumors, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡